Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santini

Showing results (41-50 of 6,998) with videos related to

Pageof 700
Sort By:
Seminars in Hematology|October 20, 2012
Treatment of low-risk myelodysplastic syndrome: hematopoietic growth factors erythropoietins and thrombopoietinsValeria Santini
Hematology. American Society of Hematology. Education Program|December 13, 2012
Novel therapeutic strategies: hypomethylating agents and beyondValeria Santini
Primary Dental Journal|June 1, 2013
Research; the key to the futureArio Santini
Endodontics & Dental Traumatology|April 1, 1987
Obturation of root canals by the standardized and step back techniquesA Santini
Leukemia Research|March 10, 2009
Is survival enough for myelodysplastic syndromes?Valeria Santini
Omega|September 28, 2020
Optimising the assignment of swabs and reagent for PCR testing during a viral epidemicAlberto Santini
European Radiology|March 13, 2024
The scientific system must bend to avoid breakingFrancesco Santini
Seminars in Hematology|January 13, 2015
On raising the "dust of blood": from unrevealing thrombopoiesis to treatment of thrombocytopenias with thrombomimetic drugsValeria Santini
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2017
First-line Therapeutic Strategies for Myelodysplastic SyndromesValeria Santini
The Lancet. Haematology|January 15, 2018
Of blood and bone: the sotatercept adventureValeria Santini
Pageof 700

Showing results (41-50 of 6,998) with videos related to

Sort By:
Pageof 700
Seminars in Hematology|October 20, 2012
Treatment of low-risk myelodysplastic syndrome: hematopoietic growth factors erythropoietins and thrombopoietinsValeria Santini
Hematology. American Society of Hematology. Education Program|December 13, 2012
Novel therapeutic strategies: hypomethylating agents and beyondValeria Santini
Primary Dental Journal|June 1, 2013
Research; the key to the futureArio Santini
Endodontics & Dental Traumatology|April 1, 1987
Obturation of root canals by the standardized and step back techniquesA Santini
Leukemia Research|March 10, 2009
Is survival enough for myelodysplastic syndromes?Valeria Santini
Omega|September 28, 2020
Optimising the assignment of swabs and reagent for PCR testing during a viral epidemicAlberto Santini
European Radiology|March 13, 2024
The scientific system must bend to avoid breakingFrancesco Santini
Seminars in Hematology|January 13, 2015
On raising the "dust of blood": from unrevealing thrombopoiesis to treatment of thrombocytopenias with thrombomimetic drugsValeria Santini
Clinical Lymphoma, Myeloma & Leukemia|August 2, 2017
First-line Therapeutic Strategies for Myelodysplastic SyndromesValeria Santini
The Lancet. Haematology|January 15, 2018
Of blood and bone: the sotatercept adventureValeria Santini
Pageof 700